Table 2. Osteoarthritis risk genes identified by SMR integrative analysis in OA.
| Gene | Chr | Top SNP | Top SNP_Chr | A1 | A2 | HEIDI Pa | SMR P | Tissue | Trait |
|---|---|---|---|---|---|---|---|---|---|
| UQCC1 | 20 | rs6579234 | 20 | G | A | 2.14E−1 | 2.05E−6 | Muscle-skeletal | SR |
| ASAP3 | 1 | rs6686497 | 1 | C | T | 5.07E−1 | 1.49E−6 | Muscle-skeletal | HD-hip |
a, HEIDI test was used to distinguish pleiotropy from the linkage. If a gene passes the HEIDI test (P>0.05), it suggests that there is a single causal variant influencing both disease risk and gene expression. Thus, expression change of this gene may have a role in disease susceptibility. SMR, summary-data-based Mendelian randomization; OA, osteoarthritis; Chr, chromosome; SNP, single-nucleotide polymorphism; HEIDI, heterogeneity in dependent instruments; HD-hip, hospital diagnosis of hip OA; SR, self-reported; OA, osteoarthritis.